A detailed history of Ensign Peak Advisors, Inc transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 37,150 shares of MRVI stock, worth $208,783. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,150
Previous 37,150 -0.0%
Holding current value
$208,783
Previous $265,000 16.23%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$6.87 - $11.34 $255,220 - $421,281
37,150 New
37,150 $265,000
Q3 2022

Nov 14, 2022

SELL
$20.6 - $30.37 $67,568 - $99,613
-3,280 Reduced 9.52%
31,160 $796,000
Q1 2022

May 16, 2022

BUY
$24.46 - $40.92 $178,068 - $297,897
7,280 Added 26.8%
34,440 $1.22 Million
Q4 2021

Feb 11, 2022

BUY
$35.0 - $45.94 $950,600 - $1.25 Million
27,160 New
27,160 $1.14 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $739M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.